According to previous research, there is evidence supporting the variability of SVCT2 expression in colorectal cancer patients and colorectal cancer cell lines, with reports showing different expression levels in patient tissue samples and cell lines. The gene discussed is SLC23A2; the disease is colorectal cancer.